Aminoglycoside Antibacterial

This page covers all Aminoglycoside Antibacterial drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Gap junction beta-2 protein, Transient receptor potential cation channel subfamily V member 5, Transient receptor potential cation channel subfamily V member 1.

Targets

Gap junction beta-2 protein · Transient receptor potential cation channel subfamily V member 5 · Transient receptor potential cation channel subfamily V member 1

Marketed (5)

• Kanacin · Bristol-Myers Squibb · Metabolic
• Garamycin · Merck & Co. · Infectious Disease
• Netromycin · Metabolic
• Cortisporin · Pfizer · Metabolic
• Arikayce Kit · Bristol-Myers Squibb · Immunology
  Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria.